Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)

Market Cap	13.24B
Revenue (ttm)	2.75B
Net Income (ttm)	585.22M
Shares Out	692.47M
EPS (ttm)	0.84
PE Ratio	22.73
Forward PE	20.67
Dividend	0.60 (3.15%)
Ex-Dividend Date	May 26, 2025

Volume	21,435,505
Average Volume	12,241,180
Open	17.86
Previous Close	19.07
Day's Range	17.86 - 19.42
52-Week Range	13.88 - 21.07
Beta	0.05
RSI	61.89
Earnings Date	Oct 24, 2025

About SHE:300181

Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally. It offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. The company also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1995
• Employees: 2,125
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300181

Financial Performance

In 2024, SHE:300181's revenue was 2.58 billion, an increase of 32.71% compared to the previous year's 1.94 billion. Earnings were 507.77 million, an increase of 32.60%.